Search

Home > ACC CardiaCast > ACC CardiaCast: Mechanisms of Action for the Newly Approved Cardiac Myosin Inhibitor Recently Approved for HCM
Podcast: ACC CardiaCast
Episode:

ACC CardiaCast: Mechanisms of Action for the Newly Approved Cardiac Myosin Inhibitor Recently Approved for HCM
Category: Science & Medicine
Duration: 00:16:57
Publish Date: 2022-06-17 16:41:00
Description:

In this episode, Drs. Matt Martinez and Ahmad Masri discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and mechanisms of action.
Total Play: 0